ABBOTT AND ROCHE CROSS-LICENSE GENE AMPLIFICATION TECHNOLOGIES TO RESOLVE "PATENT ISSUES"; ABBOTT AND PERKIN-ELMER ENTER LICENSING, SUPPLY AGREEMENTS
This article was originally published in The Gray Sheet
Executive Summary
Abbott Laboratories and Hoffmann-La Roche have cross-licensed gene amplification technologies in order to resolve "patent issues" between the companies, according to Roche.